Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | XMT-1522 |
Trade Name | |
Synonyms | XMT1522|XMT 1522 |
Drug Descriptions |
XMT-1522 is an antibody-drug conjugate (ADC) comprising an ERBB2 (HER2)-targeted antibody linked to auristatin, which delivers the cytotoxic agent to Erbb2 (Her2)-expressing tumor cells, potentially resulting in decreased tumor growth (PMID: 31292166). |
DrugClasses | HER2 (ERBB2) Antibody 76 HER2 (ERBB2) Antibody-Drug Conjugate 31 |
CAS Registry Number | NA |
NCIT ID | C132112 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
XMT-1522 | XMT-1522 | 0 | 1 |